Skip to main content

Illumina to Roll Out Sherlock Array Scanner in Q4

NEW YORK, Oct. 9 - Illumina will formally roll out its Sherlock array scanner over the next three months, a company official said today.


John Stuelpnagel, Illumina's senior vice president of operations, said the tool, a confocal scanner that acquires data from Illumina's BeadArray platform, is currently in the pilot-production stage.


Stuelpnagel spoke at the UBS Warburg global life-sciences conference, held here through Thursday.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.